DA: It will take 2-3 years before local hog population returns to pre-ASF levels
It will take another two to three years before the Philippines' swine population returns to its pre-African swine fever (ASF) levels, according to the Department of Agriculture (DA).
Interviewed on Super Radyo dzBB on Saturday, DA spokesperson Assistant Secretary Arnel de Mesa said that the Agriculture Department is already seeing signs of recovery in the local hog industry.
'Tatagal ito ng two to three years,' de Mesa said.
(This will last for two to three years.)
The DA official said the controlled vaccination of hogs is ongoing and 'naging maganda ang resulta sa mga lugar na nagkaroon ng bakuna (the results were favorable in areas where vaccination was made available).'
The DA is now awaiting the approval of the FDA for its clearance for the commercial rollout of the ASF vaccine, possibly later this year, before implementing an aggressive repopulation plan that should bring back domestic production to pre-ASF levels by 2028.
'Naghihintay na lang tayo ng kumpirmasyon mula sa FDA (Food and Drug Administration) para sa commercial release,' he said.
(We are just waiting for the confirmation from FDA for its commercial release.)
Since the first outbreak in 2019, the national hog inventory has declined from approximately 13 million heads to less than nine million heads.
The vaccine will significantly enhance the likelihood of success for the repopulation program, according to the DA. —KG, GMA Integrated News
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
GMA Network
17-07-2025
- GMA Network
US health experts to reassess hormone replacement therapy risks
HRT is taken to replace estrogen the body stops producing after menopause -- when periods end permanently -- and helps relieve symptoms such as hot flashes and vaginal discomfort. WASHINGTON - US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women around the world but long clouded by debate over its risks. HRT is taken to replace estrogen the body stops producing after menopause -- when periods end permanently -- and helps relieve symptoms such as hot flashes and vaginal discomfort. But its use has plummeted in recent years amid concerns over rare side effects, including a potential link to invasive breast cancer. Food and Drug Administration (FDA) chief Marty Makary, who convened Thursday's meeting of outside experts, has long advocated for HRT, saying its risks have been overstated. "For decades, hormone replacement therapy for women -- that is estrogen or estrogen plus progesterone -- has helped women alleviate the symptoms of menopause, including hot flashes, dryness, mood swings, weight gain and poor sleep quality, to name a few," he said in a video. He added that when initiated within a decade of the onset of the transitional period before menopause, HRT may even reduce cognitive decline, the risk of Alzheimer's, and prevent osteoporosis and cardiovascular disease. Makary blamed the drop in HRT use on a landmark clinical trial, the Women's Health Initiative, which was halted in the early 2000s after it flagged increased risks of breast cancer and stroke. But he said subsequent studies had not replicated the findings on breast cancer. Critics of the trial argue it was flawed because the participants were too far from menopause, and that the formulations used are now outdated. Still, the issue remains divisive within the medical community. The FDA's own warning label for HRT -- which can be administered through various means including orally, through skin patches, or vaginally -- cites risks including endometrial cancer, breast cancer, and life-threatening blood clots. This week, the American Journal of Physicians published an editorial that found limited benefits and significant harms associated with HRT. "Menopause is a positive life experience for many women and should not be medicalized," the authors concluded. The nature of the FDA expert meeting is also unusual. Unlike standard practice before the Trump administration, no agenda was publicly posted. Several of the named panelists have ties to companies offering menopause treatments or who belong to the advocacy group "Let's Talk Menopause," which receives funding from pharmaceutical companies and campaigns to revise the FDA warning label. — Agence France-Presse
GMA Network
11-07-2025
- GMA Network
PH lifts ban on Japan poultry
The Philippines' Department of Agriculture (DA) on Friday lifted the temporary ban on the importation of domestic and wild birds and their by-products from Japan. Agriculture Secretary Francisco Tiu Laurel Jr. issued Memorandum Order No. 36, which lifted the import ban imposed by the DA in November 2024, which also covered poultry meat, day-old chicks, eggs, and semen. . Tiu Laurel's decision came after Japan's Ministry of Agriculture, Forestry and Fisheries submitted a report to the World Organisation for Animal Health (WOAH), which confirmed that all previously reported highly pathogenic avian influenza (HPAI) cases had been resolved as of June 13, with no new outbreaks since. He said that, in accordance with WOAH guidelines and 'our own risk assessment, we have determined that Japan is bird flu free the likelihood of bird flu contamination from imports originating in Japan is negligible.' The Agriculture chief explained that the earlier import ban on Japan poultry was enacted as a precautionary measure to safeguard the local poultry industry. With the lifting of the ban, all import transactions involving poultry products from Japan must comply with the DA's existing sanitary and phytosanitary regulations and import protocols. The decision is expected to help stabilize poultry supply chains and offer local businesses greater sourcing flexibility, especially amid tight global commodity markets, according to Tiu Laurel. The latest order takes immediate effect and will remain in force until amended or formally revoked. —VAL, GMA Integrated News
GMA Network
08-07-2025
- GMA Network
DA's Tiu Laurel to take two-week medical leave
Agriculture Secretary Francisco Tiu Laurel Jr. is set to fly overseas to take a two-week medical leave starting Wednesday, July 9, 2025, to undergo a procedure he has deferred for nearly two years. In an advisory released Tuesday, the Department of Agriculture (DA) said Undersecretary Roger Navarro will be the officer-in-charge for the two weeks. The DA did not elaborate on Tiu Laurel's scheduled medical procedure, but said it was deferred since he stepped into public service in November 2023. He is expected to resume his duties by July 24, ahead of the State of the Nation Address (SONA) of President Ferdinand 'Bongbong' Marcos Jr. on July 28. 'Even while I'm abroad for my medical leave, I will continue to monitor developments on the ground. Tuloy tuloy lang ang trabaho (Work continues),' Tiu Laurel said in the advisory. According to the DA, the announcement was made to 'prevent any speculation' about Tiu Laurel's impending prolonged absence. — BAP, GMA Integrated News
